Institutional portfolio tracker

Braidwell Portfolio & AI Predictions

Explore Braidwell's latest validated 13F portfolio and Hallucination Yield AI forecasts for covered positions.

Form 13F reports holdings as of 2026-03-31 and was filed on 2026-05-15. It is delayed, can omit confidential positions, and is not the manager's current portfolio or fund NAV. Options show reported underlying value—not premium, net exposure, or investment intent.

Disclosed long book

$2.63 billion

Long positions

88

Calls / puts

0 / 0

Top 5 concentration

17.8%

Longs with AI data

2 / 88

Average AI 1Y

+13.8%

Official SEC filing ↗Exact filing eventPermanent quarter pageJSONDownload CSV

Monitored between quarterly reports

Beneficial-ownership disclosures

Schedules 13D and 13G can reveal a significant ownership event after a quarter closes. They are shown as a separate event timeline and never folded back into the 2026-03-31 Form 13F portfolio.

Surrozen, Inc.

SCHEDULE 13GSeparate ownership event

The filing reports BRAIDWELL LP's beneficial ownership as of December 31, 2025: 470,000 shares or share-equivalents representing 5.5% of the reported class. It was filed on February 17, 2026.

Official SEC disclosure ↗

DBV Technologies S.A.

SCHEDULE 13G/ASeparate ownership event

The filing reports BRAIDWELL LP's beneficial ownership as of December 31, 2024: 2,393,815 shares or share-equivalents representing 2.5% of the reported class. It was filed on February 14, 2025.

Official SEC disclosure ↗

13F filing comparison

Quarter-over-quarter changes

2025-12-31 to 2026-03-31

Newly reported

31

No longer reported

16

Increased

19

Reduced

32

Newly reported this quarter

Present now and absent from the immediately preceding comparable filing.

PositionKindSharesValue

ALPHATEC HLDGS INC

ALPHATEC HLDGS INC

LONG61,621,000$63.4 million

GUARDANT HEALTH INC

GUARDANT HEALTH INC

LONG499,712$46.2 million

GENERATE BIOMEDICINES INC

GENERATE BIOMEDICINES INC

LONG3,592,999$44.9 million

RHYTHM PHARMACEUTICALS INC

RHYTHM PHARMACEUTICALS INC

LONG310,628$27.0 million

ESTABLISHMENT LABS HLDGS INC

ESTABLISHMENT LABS HLDGS INC

LONG463,600$26.3 million

CORVUS PHARMACEUTICALS INC

CORVUS PHARMACEUTICALS INC

LONG1,752,798$25.6 million

ALPHATEC HLDGS INC

ALPHATEC HLDGS INC

LONG2,172,725$23.6 million

DAMORA THERAPEUTICS INC

DAMORA THERAPEUTICS INC

LONG894,846$23.2 million

BSX

BOSTON SCIENTIFIC CORP

LONG346,467$21.7 million

BIOAGE LABS INC

BIOAGE LABS INC

LONG1,200,587$21.0 million

TARSUS PHARMACEUTICALS INC

TARSUS PHARMACEUTICALS INC

LONG265,715$18.6 million

ELEVANCE HEALTH INC

ELEVANCE HEALTH INC

LONG62,080$18.2 million

NEKTAR THERAPEUTICS

NEKTAR THERAPEUTICS

LONG222,701$16.0 million

ACADIA HEALTHCARE COMPANY IN

ACADIA HEALTHCARE COMPANY IN

LONG645,900$15.1 million

ORIC PHARMACEUTICALS INC

ORIC PHARMACEUTICALS INC

LONG1,128,040$14.3 million

AVEANNA HEALTHCARE HLDGS INC

AVEANNA HEALTHCARE HLDGS INC

LONG2,203,506$14.2 million

ZENAS BIOPHARMA INC

ZENAS BIOPHARMA INC

LONG13,000,000$13.5 million

TG THERAPEUTICS INC

TG THERAPEUTICS INC

LONG358,800$11.9 million

CENTENE CORP DEL

CENTENE CORP DEL

LONG330,000$10.8 million

CLIMB BIO INC

CLIMB BIO INC

LONG1,529,675$10.5 million

IONIS PHARMACEUTICALS INC

IONIS PHARMACEUTICALS INC

LONG130,862$9.8 million

HELIX ACQUISITION CORP III

HELIX ACQUISITION CORP III

LONG900,000$9.3 million

VOR BIOPHARMA INC

VOR BIOPHARMA INC

LONG466,774$8.3 million

REVOLUTION MEDICINES INC

REVOLUTION MEDICINES INC

LONG84,900$8.3 million

ACLARIS THERAPEUTICS INC

ACLARIS THERAPEUTICS INC

LONG1,699,116$6.4 million

DENALI THERAPEUTICS INC

DENALI THERAPEUTICS INC

LONG296,324$5.7 million

PERKINELMER INC

PERKINELMER INC

LONG48,400$4.2 million

CELCUITY INC

CELCUITY INC

LONG29,198$3.3 million

PRAXIS PRECISION MEDICINES I

PRAXIS PRECISION MEDICINES I

LONG9,976$3.2 million

ARROWHEAD PHARMACEUTICALS IN

ARROWHEAD PHARMACEUTICALS IN

LONG2,250,000$2.3 million

VYNE THERAPEUTICS INC

VYNE THERAPEUTICS INC

LONG916,077$547,356

No longer reported this quarter

Present in the prior comparable filing and absent from this one.

PositionKindPrior sharesPrior value

ADAPTIVE BIOTECHNOLOGIES COR

ADAPTIVE BIOTECHNOLOGIES COR · COM

LONG311,991$5.1 million

ALIGN TECHNOLOGY INC

ALIGN TECHNOLOGY INC · COM

LONG381,004$59.5 million

BILLIONTOONE INC

BILLIONTOONE INC · CL A

LONG50,000$4.1 million

BIOGEN INC

BIOGEN INC · COM

LONG115,700$20.4 million

CASTLE BIOSCIENCES INC

CASTLE BIOSCIENCES INC · COM

LONG177,183$6.9 million

ICON PLC

ICON PLC · SHS

LONG73,370$13.4 million

IRHYTHM TECHNOLOGIES INC

IRHYTHM TECHNOLOGIES INC · NOTE 1.500% 9/0

LONG52,000,000$72.8 million

IRONWOOD PHARMACEUTICALS INC

IRONWOOD PHARMACEUTICALS INC · NOTE 1.500% 6/1

LONG53,405,000$50.5 million

KARYOPHARM THERAPEUTICS INC

KARYOPHARM THERAPEUTICS INC · COM NEW

LONG303,370$2.2 million

LEGEND BIOTECH CORP

LEGEND BIOTECH CORP · SPONSORED ADS

LONG1,298,142$28.2 million

ORUKA THERAPEUTICS INC

ORUKA THERAPEUTICS INC · COM

LONG84,795$2.6 million

RAPT THERAPEUTICS INC

RAPT THERAPEUTICS INC · COM NEW

LONG929,694$31.5 million

RELMADA THERAPEUTICS INC

RELMADA THERAPEUTICS INC · COM

LONG1,582,257$7.6 million

TERNS PHARMACEUTICALS INC

TERNS PHARMACEUTICALS INC · COM

LONG575,321$23.2 million

VENTYX BIOSCIENCES INC

VENTYX BIOSCIENCES INC · COM

LONG1,920,255$17.3 million

XENCOR INC

XENCOR INC · COM

LONG459,166$7.0 million

“No longer reported” means the position is absent from this comparable 13F filing. It does not prove the manager sold it: reporting thresholds, confidential treatment, corporate actions, or instrument changes can also explain the omission.

PositionKindSharesValueLong weightQuarter changeAI at filing · 1YAI now

CAI

CARIS LIFE SCIENCES INC · COM · 142152107

LONG8,009,447$143.2 million5.5%INCREASED—

1Y —

5Y —

GUARDANT HEALTH INC

GUARDANT HEALTH INC · DEBT 1.250% 2/1 · 40131MAD1

LONG60,954,000$102.6 million—REDUCED—

1Y —

5Y —

REPLIGEN CORP

REPLIGEN CORP · NOTE 1.000%12/1 · 759916AD1

LONG101,000,000$98.7 million—UNCHANGED—

1Y —

5Y —

NEOGENOMICS INC

NEOGENOMICS INC · NOTE 0.250% 1/1 · 64049MAB6

LONG100,381,000$91.8 million—UNCHANGED—

1Y —

5Y —

NEUROCRINE BIOSCIENCES INC

NEUROCRINE BIOSCIENCES INC · COM · 64125C109

LONG652,121$85.9 million3.3%REDUCED—

1Y —

5Y —

GLAUKOS CORP

GLAUKOS CORP · COM · 377322102

LONG763,505$82.2 million3.1%REDUCED—

1Y —

5Y —

CENTESSA PHARMACEUTICALS PLC

CENTESSA PHARMACEUTICALS PLC · SPONSORED ADS · 152309100

LONG1,986,768$78.9 million3.0%REDUCED—

1Y —

5Y —

XENON PHARMACEUTICALS INC

XENON PHARMACEUTICALS INC · COM · 98420N105

LONG1,338,452$77.8 million3.0%REDUCED—

1Y —

5Y —

DIANTHUS THERAPEUTICS INC

DIANTHUS THERAPEUTICS INC · COM · 252828108

LONG899,364$75.5 million2.9%REDUCED—

1Y —

5Y —

EDGEWISE THERAPEUTICS INC

EDGEWISE THERAPEUTICS INC · COM · 28036F105

LONG2,347,583$73.9 million2.8%REDUCED—

1Y —

5Y —

IRHYTHM HOLDINGS INC

IRHYTHM HOLDINGS INC · COM · 450056106

LONG610,192$72.0 million2.7%INCREASED—

1Y —

5Y —

NUVALENT INC

NUVALENT INC · COM · 670703107

LONG700,429$71.8 million2.7%REDUCED—

1Y —

5Y —

KODIAK SCIENCES INC

KODIAK SCIENCES INC · COM · 50015M109

LONG1,818,665$69.3 million2.6%REDUCED—

1Y —

5Y —

CG ONCOLOGY INC

CG ONCOLOGY INC · COM · 156944100

LONG984,783$66.7 million2.5%REDUCED—

1Y —

5Y —

ALPHATEC HLDGS INC

ALPHATEC HLDGS INC · NOTE 0.750% 3/1 · 02081GAD4

LONG61,621,000$63.4 million—NEWLY REPORTED—

1Y —

5Y —

ARGENX SE

ARGENX SE · SPONSORED ADR · 04016X101

LONG84,939$62.0 million2.4%INCREASED—

1Y —

5Y —

HINGE HEALTH INC

HINGE HEALTH INC · CL A · 433313103

LONG1,455,123$56.1 million2.1%INCREASED—

1Y —

5Y —

ACADIA PHARMACEUTICALS INC

ACADIA PHARMACEUTICALS INC · COM · 004225108

LONG2,471,199$55.0 million2.1%INCREASED—

1Y —

5Y —

MONTE ROSA THERAPEUTICS INC

MONTE ROSA THERAPEUTICS INC · COM · 61225M102

LONG3,206,574$52.7 million2.0%INCREASED—

1Y —

5Y —

KRYSTAL BIOTECH INC

KRYSTAL BIOTECH INC · COM · 501147102

LONG182,425$47.1 million1.8%REDUCED—

1Y —

5Y —

SPYRE THERAPEUTICS INC

SPYRE THERAPEUTICS INC · COM NEW · 00773J202

LONG932,823$47.1 million1.8%REDUCED—

1Y —

5Y —

GUARDANT HEALTH INC

GUARDANT HEALTH INC · COM · 40131M109

LONG499,712$46.2 million1.8%NEWLY REPORTED—

1Y —

5Y —

TMO

Thermo Fisher Scientific Inc.

LONG92,915$45.7 million1.7%INCREASED12.5%

1Y +12.1%

5Y +69.0% · 5 models

GENERATE BIOMEDICINES INC

GENERATE BIOMEDICINES INC · COM SHS · 370920100

LONG3,592,999$44.9 million1.7%NEWLY REPORTED—

1Y —

5Y —

MBX BIOSCIENCES INC

MBX BIOSCIENCES INC · COM · 55287L101

LONG1,492,467$44.6 million1.7%INCREASED—

1Y —

5Y —

BRIGHTSPRING HEALTH SVCS INC

BRIGHTSPRING HEALTH SVCS INC · COM · 10950A106

LONG1,016,562$43.3 million1.6%REDUCED—

1Y —

5Y —

CELLDEX THERAPEUTICS INC NEW

CELLDEX THERAPEUTICS INC NEW · COM NEW · 15117B202

LONG1,356,082$43.0 million1.6%REDUCED—

1Y —

5Y —

NEOGENOMICS INC

NEOGENOMICS INC · COM NEW · 64049M209

LONG5,617,402$41.7 million1.6%INCREASED—

1Y —

5Y —

APOGEE THERAPEUTICS INC

APOGEE THERAPEUTICS INC · COM · 03770N101

LONG478,667$40.3 million1.5%REDUCED—

1Y —

5Y —

BRIGHT MINDS BIOSCIENCES INC

BRIGHT MINDS BIOSCIENCES INC · COM NEW · 10919W405

LONG539,708$39.4 million1.5%INCREASED—

1Y —

5Y —

CAREDX INC

CAREDX INC · COM · 14167L103

LONG2,173,146$37.7 million1.4%INCREASED—

1Y —

5Y —

ISRG

INTUITIVE SURGICAL INC · COM NEW · 46120E602

LONG77,297$35.6 million1.4%REDUCED—

1Y +15.4%

5Y +103.0% · 5 models

INSPIRE MED SYS INC

INSPIRE MED SYS INC · COM · 457730109

LONG677,570$34.9 million1.3%INCREASED—

1Y —

5Y —

PENUMBRA INC

PENUMBRA INC · COM · 70975L107

LONG105,352$34.6 million1.3%REDUCED—

1Y —

5Y —

TRANSMEDICS GROUP INC

TRANSMEDICS GROUP INC · COM · 89377M109

LONG329,391$32.7 million1.2%INCREASED—

1Y —

5Y —

SOLENO THERAPEUTICS INC

SOLENO THERAPEUTICS INC · COM · 834203309

LONG959,259$32.1 million1.2%REDUCED—

1Y —

5Y —

DYNE THERAPEUTICS INC

DYNE THERAPEUTICS INC · COM · 26818M108

LONG1,681,998$30.5 million1.2%INCREASED—

1Y —

5Y —

MARAVAI LIFESCIENCES HLDGS I

MARAVAI LIFESCIENCES HLDGS I · COM CL A · 56600D107

LONG10,240,164$29.0 million1.1%INCREASED—

1Y —

5Y —

ILLUMINA INC

ILLUMINA INC · COM · 452327109

LONG229,215$28.3 million1.1%REDUCED—

1Y —

5Y —

KYMERA THERAPEUTICS INC

KYMERA THERAPEUTICS INC · COM · 501575104

LONG337,559$28.1 million1.1%REDUCED—

1Y —

5Y —

BIOMARIN PHARMACEUTICAL INC

BIOMARIN PHARMACEUTICAL INC · COM · 09061G101

LONG497,020$28.1 million1.1%REDUCED—

1Y —

5Y —

NURIX THERAPEUTICS INC

NURIX THERAPEUTICS INC · COM · 67080M103

LONG1,750,766$27.1 million1.0%REDUCED—

1Y —

5Y —

RHYTHM PHARMACEUTICALS INC

RHYTHM PHARMACEUTICALS INC · COM · 76243J105

LONG310,628$27.0 million1.0%NEWLY REPORTED—

1Y —

5Y —

DANAHER CORPORATION

DANAHER CORPORATION · COM · 235851102

LONG139,327$26.4 million1.0%INCREASED—

1Y —

5Y —

ESTABLISHMENT LABS HLDGS INC

ESTABLISHMENT LABS HLDGS INC · COM · G31249108

LONG463,600$26.3 million1.0%NEWLY REPORTED—

1Y —

5Y —

TECTONIC THERAPEUTIC INC

TECTONIC THERAPEUTIC INC · COM · 878972108

LONG847,151$26.2 million1.0%REDUCED—

1Y —

5Y —

NTRA

NATERA INC · COM · 632307104

LONG129,000$25.8 million1.0%INCREASED—

1Y —

5Y —

CORVUS PHARMACEUTICALS INC

CORVUS PHARMACEUTICALS INC · COM · 221015100

LONG1,752,798$25.6 million1.0%NEWLY REPORTED—

1Y —

5Y —

FULCRUM THERAPEUTICS INC

FULCRUM THERAPEUTICS INC · COM · 359616109

LONG3,134,922$24.0 million0.9%INCREASED—

1Y —

5Y —

ZURA BIO LTD

ZURA BIO LTD · CLASS A ORD SHS · G9TY5A101

LONG3,988,989$23.7 million0.9%INCREASED—

1Y —

5Y —

ALPHATEC HLDGS INC

ALPHATEC HLDGS INC · COM NEW · 02081G201

LONG2,172,725$23.6 million0.9%NEWLY REPORTED—

1Y —

5Y —

DAMORA THERAPEUTICS INC

DAMORA THERAPEUTICS INC · COM NEW · 36322Q206

LONG894,846$23.2 million0.9%NEWLY REPORTED—

1Y —

5Y —

BSX

Boston Scientific

LONG346,467$21.7 million0.8%NEWLY REPORTED—

1Y —

5Y —

VERA THERAPEUTICS INC

VERA THERAPEUTICS INC · CL A · 92337R101

LONG523,824$21.1 million0.8%REDUCED—

1Y —

5Y —

BIOAGE LABS INC

BIOAGE LABS INC · COM · 09077V100

LONG1,200,587$21.0 million0.8%NEWLY REPORTED—

1Y —

5Y —

CVS HEALTH CORP

CVS HEALTH CORP · COM · 126650100

LONG290,700$20.9 million0.8%REDUCED—

1Y —

5Y —

TARSUS PHARMACEUTICALS INC

TARSUS PHARMACEUTICALS INC · COM · 87650L103

LONG265,715$18.6 million0.7%NEWLY REPORTED—

1Y —

5Y —

ELEVANCE HEALTH INC

ELEVANCE HEALTH INC · COM · 036752103

LONG62,080$18.2 million0.7%NEWLY REPORTED—

1Y —

5Y —

ORTHOPEDIATRICS CORP

ORTHOPEDIATRICS CORP · COM · 68752L100

LONG1,100,370$17.5 million0.7%UNCHANGED—

1Y —

5Y —

ENGENE HOLDINGS INC

ENGENE HOLDINGS INC · COM · 29286M105

LONG2,456,870$16.7 million0.6%REDUCED—

1Y —

5Y —

NEKTAR THERAPEUTICS

NEKTAR THERAPEUTICS · COM NEW · 640268306

LONG222,701$16.0 million0.6%NEWLY REPORTED—

1Y —

5Y —

ACADIA HEALTHCARE COMPANY IN

ACADIA HEALTHCARE COMPANY IN · COM · 00404A109

LONG645,900$15.1 million0.6%NEWLY REPORTED—

1Y —

5Y —

ORIC PHARMACEUTICALS INC

ORIC PHARMACEUTICALS INC · COM · 68622P109

LONG1,128,040$14.3 million0.5%NEWLY REPORTED—

1Y —

5Y —

AVEANNA HEALTHCARE HLDGS INC

AVEANNA HEALTHCARE HLDGS INC · COM · 05356F105

LONG2,203,506$14.2 million0.5%NEWLY REPORTED—

1Y —

5Y —

X4 PHARMACEUTICALS INC

X4 PHARMACEUTICALS INC · COM NEW · 98420X202

LONG3,272,954$13.5 million0.5%REDUCED—

1Y —

5Y —

ZENAS BIOPHARMA INC

ZENAS BIOPHARMA INC · NOTE 2.500% 4/0 · 98937LAA3

LONG13,000,000$13.5 million—NEWLY REPORTED—

1Y —

5Y —

KINIKSA PHARMACEUTICALS INTL

KINIKSA PHARMACEUTICALS INTL · ORD SHS CL A · G52694109

LONG272,522$13.1 million0.5%REDUCED—

1Y —

5Y —

EVOLUS INC

EVOLUS INC · COM · 30052C107

LONG3,105,209$12.8 million0.5%UNCHANGED—

1Y —

5Y —

TG THERAPEUTICS INC

TG THERAPEUTICS INC · COM · 88322Q108

LONG358,800$11.9 million0.5%NEWLY REPORTED—

1Y —

5Y —

SURROZEN INC

SURROZEN INC · COM NEW · 86889P208

LONG396,100$11.5 million0.4%REDUCED—

1Y —

5Y —

CENTENE CORP DEL

CENTENE CORP DEL · COM · 15135B101

LONG330,000$10.8 million0.4%NEWLY REPORTED—

1Y —

5Y —

CLIMB BIO INC

CLIMB BIO INC · COM · 28658R106

LONG1,529,675$10.5 million0.4%NEWLY REPORTED—

1Y —

5Y —

COMPASS THERAPEUTICS INC

COMPASS THERAPEUTICS INC · COM · 20454B104

LONG1,965,106$10.4 million0.4%REDUCED—

1Y —

5Y —

IONIS PHARMACEUTICALS INC

IONIS PHARMACEUTICALS INC · COM · 462222100

LONG130,862$9.8 million0.4%NEWLY REPORTED—

1Y —

5Y —

HELIX ACQUISITION CORP III

HELIX ACQUISITION CORP III · USD CL A ORD SHS · G4444S107

LONG900,000$9.3 million0.4%NEWLY REPORTED—

1Y —

5Y —

VOR BIOPHARMA INC

VOR BIOPHARMA INC · COM NEW · 929033207

LONG466,774$8.3 million0.3%NEWLY REPORTED—

1Y —

5Y —

REVOLUTION MEDICINES INC

REVOLUTION MEDICINES INC · COM · 76155X100

LONG84,900$8.3 million0.3%NEWLY REPORTED—

1Y —

5Y —

GRAIL INC

GRAIL INC · COM · 384747101

LONG142,755$7.4 million0.3%UNCHANGED—

1Y —

5Y —

ACLARIS THERAPEUTICS INC

ACLARIS THERAPEUTICS INC · COM · 00461U105

LONG1,699,116$6.4 million0.2%NEWLY REPORTED—

1Y —

5Y —

DENALI THERAPEUTICS INC

DENALI THERAPEUTICS INC · COM · 24823R105

LONG296,324$5.7 million0.2%NEWLY REPORTED—

1Y —

5Y —

REPLIGEN CORP

REPLIGEN CORP · COM · 759916109

LONG47,500$5.6 million0.2%REDUCED—

1Y —

5Y —

HARROW INC

HARROW INC · COM · 415858109

LONG156,419$5.5 million0.2%REDUCED—

1Y —

5Y —

PERKINELMER INC

PERKINELMER INC · COM · 714046109

LONG48,400$4.2 million0.2%NEWLY REPORTED—

1Y —

5Y —

CELCUITY INC

CELCUITY INC · COM · 15102K100

LONG29,198$3.3 million0.1%NEWLY REPORTED—

1Y —

5Y —

PRAXIS PRECISION MEDICINES I

PRAXIS PRECISION MEDICINES I · COM NEW · 74006W207

LONG9,976$3.2 million0.1%NEWLY REPORTED—

1Y —

5Y —

ARROWHEAD PHARMACEUTICALS IN

ARROWHEAD PHARMACEUTICALS IN · NOTE 1/1 · 04280AAC4

LONG2,250,000$2.3 million—NEWLY REPORTED—

1Y —

5Y —

PULMONX CORP

PULMONX CORP · COM · 745848101

LONG752,541$970,7780.0%UNCHANGED—

1Y —

5Y —

VYNE THERAPEUTICS INC

VYNE THERAPEUTICS INC · COM · 92941V308

LONG916,077$547,3560.0%NEWLY REPORTED—

1Y —

5Y —

AI outlook values are averages across the latest successful run per covered model at the labeled cutoff. “No longer reported” does not necessarily mean sold; thresholds, confidential treatment, corporate actions, or instrument changes may explain an omission. Reviewed API mapping covers 2.6%of disclosed long-book value; exact editorial CUSIP mappings may add current-only AI coverage on this public page. Research use only. No warranty and not investment advice.

Filing history

Get filing alerts →

Every filing event remains separate, including notices and amendments. Open a holdings date for the canonical portfolio through its latest filing, or an accession for the exact source event.

Holdings dateFiledFormProcessingAccession
2026-03-312026-05-1513F-HRVALIDATED0001420506-26-001145
2025-12-312026-02-1713F-HRVALIDATED0001420506-26-000586
2025-09-302025-11-1413F-HRVALIDATED0001420506-25-003410
2025-06-302025-08-1413F-HRVALIDATED0001420506-25-002183
2025-03-312025-05-1513F-HRVALIDATED0001420506-25-001293
2024-12-312025-02-1413F-HRQUARANTINED0001920938-25-000002
2024-09-302024-11-1413F-HRVALIDATED0001920938-24-000006
2024-06-302024-08-1413F-HRVALIDATED0001420506-24-001566
2024-03-312024-05-1513F-HRVALIDATED0001920938-24-000004
2023-12-312024-02-1413F-HRVALIDATED0001420506-24-000478
2023-09-302023-11-1413F-HRVALIDATED0001420506-23-002213
2023-06-302023-08-1413F-HRVALIDATED0001420506-23-001695
2023-03-312023-05-1513F-HRVALIDATED0000905148-23-000454
2022-12-312023-02-1413F-HRVALIDATED0001420506-23-000696
Open interactive changes in the app